| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82249-010-12 | 82249-010 | HUMAN PRESCRIPTION DRUG | Abiraterone | Abiraterone acetate | TABLET | ORAL; ORAL | 20220627 | N/A | ANDA | ANDA208339 | CivicaScript, LLC | ABIRATERONE ACETATE | 250 mg/1 | 120 TABLET in 1 BOTTLE, PLASTIC (82249-010-12) |
| 0143-9597-21 | 0143-9597 | HUMAN PRESCRIPTION DRUG | Abiraterone | Abiraterone acetate | TABLET | ORAL | 20181123 | N/A | ANDA | ANDA208339 | Hikma Pharmaceuticals USA Inc. | ABIRATERONE ACETATE | 250 mg/1 | 120 TABLET in 1 BOTTLE (0143-9597-21) |
| 72789-213-98 | 72789-213 | HUMAN PRESCRIPTION DRUG | Abiraterone | Abiraterone acetate | TABLET | ORAL | 20211011 | N/A | ANDA | ANDA208339 | PD-Rx Pharmaceuticals, Inc. | ABIRATERONE ACETATE | 250 mg/1 | 120 TABLET in 1 BOTTLE, PLASTIC (72789-213-98) |